Skip to content

Inga Griškova-bulanova

4 papers in the library · 69 citations · publishing 2018-2026

Papers

Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers

Psychopharmacology January 5, 2018 Anna Bravermanová, Michaela Viktorinová, Filip Tylš et al. 50 citations

Psilocybin, a psychedelic that activates 5-HT2A receptors, disrupted early perceptual and higher-order cognitive processing in healthy volunteers but left pre-attentive cognition intact. In a double-blind, placebo-controlled crossover trial, 20 participants (10 men, 10 women) received 0.26 mg/kg of psilocybin orally. The drug produced robust psychedelic effects and psychotic-like symptoms, decreased the amplitude of the P300 event-related potential (a marker of attentive processing) and the N100 (an early perceptual marker), but did not affect mismatch negativity (MMN), a measure of pre-attentive processing. The disruption of P300 correlated with the intensity of the psychedelic state, which depended on psilocin serum levels. These findings suggest that 5-HT2A receptors play a role in altered information processing in psychosis and schizophrenia, particularly at early perceptual and higher-order cognitive levels.

Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience

Journal of Personalized Medicine June 19, 2022 Vojtěch Viktorin, Inga Griškova-bulanova, Aleksandras Voicikas et al. 19 citations

Psilocybin, a psychedelic compound, reduces the brain's ability to synchronize its electrical activity at 40 Hz in response to auditory clicks. In a double-blind, placebo-controlled crossover study, 20 healthy volunteers received either psilocybin (0.26 mg/kg) or placebo. Measurements taken before and after ingestion showed that psilocybin decreased the phase-locking index and amplitude of the 40 Hz auditory steady-state response, and the degree of this reduction correlated with changes in cognition and affect. These findings support the role of gamma oscillations in cognitive processing and their disruption in psychosis.

Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMT

bioRxiv Preprint Server May 5, 2026 Povilas Tarailis, Inga Griškova-bulanova preprint

Frequency-resolved EEG microstate analysis can detect changes in brain dynamics that broadband analysis misses. In two public datasets, psilocybin microdosing produced subtle, frequency-specific effects—reduced global field power and altered delta- and theta-band microstate parameters—without broadband spatiotemporal changes. Acute inhaled DMT caused broader alterations across broadband, delta, theta, and alpha activity, indicating more extensive reorganization. In both conditions, delta-band microstate C showed increased duration and microstate D decreased occurrence, though these overlaps should be interpreted cautiously due to differences in dose, route, and context. The findings suggest frequency-resolved analysis is useful for characterizing altered resting-state brain dynamics.

Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in rats.

Journal of neurophysiology April 1, 2026 Inga Griškova-bulanova, Čestmír Vejmola, Tomáš Páleníček

Psilocin, the active metabolite of psilocybin, selectively disrupts auditory neural synchronization in rats in a frequency- and region-specific manner. In eight adult male Wistar rats implanted with cortical electrodes, psilocin (4 mg/kg) reduced phase-locking at 40 Hz stimulation in the right temporal cortex, with no significant changes in frontal or left temporal regions or at 80 Hz stimulation. Spectral power was globally reduced at 80 Hz after psilocin, but not consistently at 40 Hz. These results indicate that low-gamma oscillations are sensitive to serotonergic modulation via 5-HT2A receptor signaling, supporting auditory steady-state responses as translational biomarkers for altered perceptual states.